{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:40:16Z","timestamp":1790242816464,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To compare risk of reintervention, long-term clinical outcomes, and health care utilization among women who have bulk symptoms from leiomyoma and who underwent the following procedures: hysterectomy, myomectomy, uterine artery embolization, and magnetic resonance-guided, focused ultrasound surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This was a retrospective analysis of administrative claims from a large U.S. commercial insurance database. Women aged 18\u201354 years undergoing any of the previously mentioned leiomyoma procedures between 2000 and 2013 were included. We assessed the following outcome measures: risk of reintervention between uterine-sparing procedures, risk of other surgical procedures or complications of the index procedure, 5-year health care utilization, pregnancy rates, and reproductive outcomes. Propensity score matching along with Cox proportional hazard models were used to adjust for differences in baseline characteristics between study cohorts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Among the 135,522 study-eligible women with mean follow-up of 3.4 years, hysterectomy was the most common first-line procedural therapy (111,324 [82.2%]) followed by myomectomy (19,965 [14.7%]), uterine artery embolization (4,186 [3.1%]) and magnetic resonance-guided focused ultrasound surgery (47 [0.0003%]). Small but statistically significant differences were noted for uterine artery embolization and myomectomy in reintervention rate (17.1% compared with 15.0%, <jats:italic toggle=\"yes\">P<\/jats:italic>=.02), subsequent hysterectomy rates (13.2% compared with 11.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.01) and subsequent complications from index procedures (18.1% compared with 24.6%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001). During follow-up, women undergoing myomectomy had lower leiomyoma-related health care utilization, but had higher all-cause outpatient services. Pregnancy rates were 7.5% and 2.2% among myomectomy and uterine artery embolization cohorts, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001) with both cohorts having similar rates of adverse reproductive outcome (69.4%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Although the overwhelming majority of women having leiomyoma with bulk symptoms underwent hysterectomy as their first treatment procedure, among those undergoing uterine-sparing index procedures, approximately one seventh had a reintervention, and one tenth ended up undergoing hysterectomy during follow-up. Compared with women undergoing myomectomy, women undergoing uterine artery embolization had a higher risk of reintervention, lower risk of subsequent complications, but similar rate of adverse reproductive outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002331","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T21:24:41Z","timestamp":1507670681000},"page":"1047-1056","source":"Crossref","is-referenced-by-count":40,"title":["Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database"],"prefix":"10.1097","volume":"130","author":[{"given":"Bijan J.","family":"Borah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon K.","family":"Laughlin-Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert C.","family":"Heien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/JOM.0b013e31805f6cf2","article-title":"The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids","volume":"49","author":"Lee","year":"2007","journal-title":"J Occup Environ Med"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"195","author":"Flynn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"396\u2013403","DOI":"10.1097\/AOG.0b013e31820780e3","article-title":"Uterine leiomyomas: individualizing the approach to a heterogeneous condition","volume":"117","author":"Laughlin","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"R8-20230711","first-page":"CR24","article-title":"Hysterectomy surveillance in the United States, 1997 through 2005","volume":"14","author":"Merrill","year":"2008","journal-title":"Med Sci Monit"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/AOG.0b013e318299a6cf","article-title":"Nationwide trends in the performance of inpatient hysterectomy in the United States","volume":"122","author":"Wright","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0020-7292(01)00405-2","article-title":"Pregnancy following uterine fibroid embolization","volume":"74","author":"McLucas","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000149156.07061.1f","article-title":"Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial","volume":"105","author":"Pron","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00270-007-9195-2","article-title":"Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy","volume":"31","author":"Mara","year":"2008","journal-title":"Cardiovasc Interv Radiol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.gco.0000233934.13684.cb","article-title":"Pregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomy","volume":"18","author":"Goldberg","year":"2006","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R16-20230711","first-page":"864","article-title":"Comparison of long-term outcomes of myomectomy and uterine artery embolization","volume":"100","author":"Broder","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejogrb.2005.10.008","article-title":"Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial","volume":"126","author":"Mara","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00270-011-0228-5","article-title":"Uterine artery embolization versus myomectomy: impact on quality of life\u2014results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial","volume":"35","author":"Manyonda","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jvir.2010.03.012","article-title":"Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison","volume":"21","author":"Narayan","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/cer.13.89","article-title":"Applications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?","volume":"3","author":"Borah","year":"2014","journal-title":"J Comp Eff Res"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/humrep\/dem105","article-title":"Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy","volume":"22","author":"Hehenkamp","year":"2007","journal-title":"Hum Reprod"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jvir.2012.12.002","article-title":"The impact of uterine artery embolization on ovarian function","volume":"24","author":"Kaump","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0b013e318183fbab","article-title":"Alternatives to hysterectomy in the management of leiomyomas","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"34.e1","DOI":"10.1016\/j.ajog.2007.05.039","article-title":"Inpatient hysterectomy surveillance in the United States, 2000-2004","volume":"198","author":"Whiteman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2006.11.080","article-title":"Influence of hysterectomy on long-term fracture risk","volume":"88","author":"Melton","year":"2007","journal-title":"Fertil Steril"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"664.e1","DOI":"10.1016\/j.ajog.2007.08.064","article-title":"Incidence of pelvic floor repair after hysterectomy: a population-based cohort study","volume":"197","author":"Blandon","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/01.CIR.0000159344.21672.FD","article-title":"Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative observational study","volume":"111","author":"Howard","year":"2005","journal-title":"Circulation"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000314681","article-title":"Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study","volume":"30","author":"Phung","year":"2009","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201711000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:33:15Z","timestamp":1689103995000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201711000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002331","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}